NIH offers access to All of Us blood plasma, serum, and DNA for externally funded partnered studies that advance precision medicine and add data for broad research use; clinical trials are not allowed.
Funder: National Institutes of Health
Due Dates: July 1, 2026 (New only) | October 30, 2026 (New and resubmissions) | March 1, 2027 (New and resubmissions; closing date)
Funding Amounts: No monetary funding; biospecimen resource access for up to 3 years
Summary: Provides access to All of Us biospecimens to generate assay data supporting precision medicine and broad research use.
Key Information: Applicants must fund all study costs externally and return newly generated assay data to All of Us.
The NIH All of Us Research Program offers X01 Resource Access Awards for studies analyzing stored plasma, serum, and extracted genomic DNA from its Biobank. These externally sponsored partnered research studies generate new assay data, link it with existing All of Us data, and expand the Researcher Workbench dataset for the scientific community. Only biospecimens collected at a single time point are currently available through this opportunity.
The program prioritizes large-scale projects using validated assays with broad scientific utility. Areas of interest include integrated multiomics, early disease detection, biomarker discovery or validation, incident-disease risk models, disease stratification, and therapeutic-response prediction. Projects covering the entire population or large subsets, and assays illuminating pathways underlying common, chronic, or pressing health conditions, receive priority. Rare-disease investigations are considered individually.